Patent details

Herbas

VPB

Print

EN | LT

LT - USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS

EN - USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 47/48
		A61K 38/26
		C07K 14/605
		A61P 3/10

European patent
(11)	Number of the document	2073834
(13)	Kind of document	T
(96)	European patent application number	07842306.8
	Date of filing the European patent application	2007-09-12
(97)	Date of publication of the European application	2009-07-01
(45)	Date of publication and mention of the grant of the patent	2013-10-23
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2007/078226
	Date	2007-09-12

PCT application publication
(87)	Number	WO 2008/033888
	Date	2008-03-20

Priority applications
(30)	Number	Date	Country code
	825472 P	2006-09-13	US
	868391 P	2006-12-04	US

Inventors
(72)	BUSH, Mark, A., US MATTHEWS, Jessica, E., US WALKER, Susan, E., US

Grantee
(73)	GlaxoSmithKline LLC, One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, US

Title
(54)	USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS
	USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS